Ingevity Corporation (NGVT) Key Metrics
NGVT valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $2.40B
- Enterprise value
- $3.61B
- P/E (TTM)
- 99.7 10-yr median 21.1
- Forward P/E
- 10.0
- PEG ratio
- 2.41
- Price / sales
- 2.1 10-yr median 2.3
- Price / book
- 52.6 10-yr median 7.3
- EV / EBITDA
- 17.4 10-yr median 13.3
- Dividend yield
- —
- Beta
- 1.14
NGVT key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsNGVT valuation Price multiples at each fiscal year-end price.
NGVT returns How much profit the business earns on the capital it uses.
NGVT per-share figures Results divided by the shares outstanding at year-end.
NGVT financial health Debt, liquidity and how easily interest is covered.
NGVT efficiency & capital use Working capital cycle and where the cash goes.
NGVT valuation history
NGVT returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
NGVT debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
NGVT cash returned to shareholders
NGVT price vs earnings per share
NGVT key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $2.14B | $1.48B | $1.72B | $2.71B | $2.87B | $3.15B | $3.69B | $3.57B | $2.99B | $2.32B |
| Enterprise value | $3.31B | $2.87B | $3.16B | $4.16B | $3.88B | $4.20B | $4.90B | $4.24B | $3.36B | $2.78B |
| P/E ratio | — | — | — | 12.8 | 24.3 | 17.3 | 20.1 | 21.1 | 23.7 | 65.9 |
| Price / sales | 1.8 | 1.1 | 1.0 | 1.6 | 2.1 | 2.6 | 2.9 | 3.1 | 3.1 | 2.6 |
| Price / book | 72.1 | 7.6 | 2.7 | 3.9 | 4.3 | 4.9 | 6.9 | 10.5 | 10.8 | 17.2 |
| Price / free cash flow | 7.8 | 29.0 | 18.1 | 15.9 | 15.2 | 12.8 | 22.9 | 22.6 | 24.6 | 32.6 |
| Price / operating cash flow | 6.5 | 11.5 | 8.4 | 8.6 | 9.8 | 8.9 | 13.4 | 14.1 | 17.2 | 18.1 |
| EV / sales | 2.8 | 2.0 | 1.9 | 2.5 | 2.8 | 3.5 | 3.8 | 3.7 | 3.5 | 3.1 |
| EV / EBITDA | 88.4 | — | 15.3 | 9.5 | 12.0 | 11.0 | 11.9 | 13.3 | 13.8 | 14.0 |
| EV / free cash flow | 12.1 | 56.2 | 33.2 | 24.4 | 20.5 | 17.0 | 30.4 | 26.8 | 27.6 | 39.0 |
| Earnings yield | −7.8% | −29.1% | −0.3% | 7.8% | 4.1% | 5.8% | 5.0% | 4.7% | 4.2% | 1.5% |
| Free cash flow yield | 12.8% | 3.4% | 5.5% | 6.3% | 6.6% | 7.8% | 4.4% | 4.4% | 4.1% | 3.1% |
| Dividend yield | — | — | — | 0.2% | 0.2% | 0.1% | 0.1% | 0.4% | 0.0% | 19.3% |
| Shareholder yield (dividends + buybacks) | 2.6% | 0.2% | 5.3% | 5.5% | 4.0% | 2.9% | 0.3% | 1.8% | 0.2% | 19.3% |
| Share price at fiscal year-end | $59.18 | $40.75 | $47.22 | $70.44 | $71.70 | $75.73 | $87.38 | $83.69 | $70.47 | $54.86 |
| Per share | ||||||||||
| Revenue per share | $32.25 | $38.72 | $46.36 | $43.37 | $34.74 | $29.27 | $30.64 | $26.61 | $22.88 | $21.47 |
| Earnings per share | −$4.62 | −$11.85 | −$0.15 | $5.50 | $2.95 | $4.37 | $4.35 | $3.97 | $2.97 | $0.83 |
| Operating cash flow per share | $9.15 | $3.54 | $5.62 | $8.15 | $7.32 | $8.48 | $6.53 | $5.92 | $4.10 | $3.02 |
| Free cash flow per share | $7.56 | $1.40 | $2.61 | $4.44 | $4.73 | $5.93 | $3.81 | $3.71 | $2.86 | $1.68 |
| Cash per share | $2.16 | $1.87 | $2.63 | $1.99 | $6.87 | $6.20 | $1.34 | $1.82 | $2.07 | $0.72 |
| Book value per share | $0.82 | $5.37 | $17.30 | $18.15 | $16.82 | $15.58 | $12.58 | $7.97 | $6.53 | $3.18 |
| Tangible book value per share | −$5.25 | −$8.37 | −$7.71 | −$7.17 | −$2.64 | −$4.12 | −$7.21 | $1.96 | $5.69 | $2.46 |
| Dividends per share | — | — | — | $0.11 | $0.12 | $0.09 | $0.10 | $0.36 | $0.00 | $10.60 |
| Capex per share | $1.59 | $2.14 | $3.01 | $3.70 | $2.59 | $2.55 | $2.72 | $2.20 | $1.24 | $1.34 |
| Debt per share | $34.33 | $40.05 | $42.05 | $39.79 | $32.13 | $31.52 | $30.05 | $17.66 | $10.67 | $11.56 |
| Shares outstanding | 36.2M | 36.3M | 36.5M | 38.5M | 40.1M | 41.5M | 42.2M | 42.6M | 42.5M | 42.3M |
| Change in shares outstanding | −0.3% | −0.5% | −5.1% | −4.0% | −3.6% | −1.5% | −0.9% | +0.2% | +0.5% | +0.5% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −148.6% | −104.1% | −0.8% | 30.8% | 17.9% | 30.8% | 42.2% | 54.8% | 61.3% | 10.8% |
| Return on invested capital (ROIC) | 14.9% | 11.2% | 9.6% | 13.9% | 13.2% | 13.3% | 19.2% | 26.0% | 27.2% | 14.0% |
| Return on assets (ROA) | −9.1% | −18.5% | −0.2% | 8.1% | 4.9% | 8.1% | 10.6% | 15.1% | 14.3% | 4.4% |
| Return on tangible assets | −11.7% | −28.2% | −0.3% | 12.0% | 7.0% | 12.0% | 14.0% | 16.0% | 14.1% | 4.4% |
| Free cash flow margin | 23.4% | 3.6% | 5.6% | 10.2% | 13.6% | 20.3% | 12.4% | 13.9% | 12.5% | 7.8% |
| Income quality (OCF / net income) | — | — | — | 1.48 | 2.48 | 1.94 | 1.50 | 1.49 | 1.38 | 3.63 |
| Financial health | ||||||||||
| Total debt | $1.24B | $1.45B | $1.53B | $1.53B | $1.29B | $1.31B | $1.27B | $752.4M | $453.4M | $488.8M |
| Cash & short-term investments | $78.1M | $68.0M | $95.9M | $76.7M | $275.4M | $257.7M | $56.5M | $77.5M | $87.9M | $30.5M |
| Net debt | $1.16B | $1.39B | $1.44B | $1.45B | $1.01B | $1.05B | $1.21B | $674.9M | $365.5M | $458.3M |
| Debt / equity | 41.84 | 7.45 | 2.43 | 2.19 | 1.91 | 2.02 | 2.39 | 2.22 | 1.63 | 3.63 |
| Debt / assets | 0.75 | 0.72 | 0.58 | 0.56 | 0.52 | 0.56 | 0.59 | 0.57 | 0.49 | 0.59 |
| Net debt / EBITDA | 31.14 | — | 6.98 | 3.30 | 3.12 | 2.75 | 2.93 | 2.11 | 1.50 | 2.30 |
| Current ratio | 1.33 | 1.87 | 1.81 | 2.25 | 2.70 | 2.81 | 2.15 | 2.31 | 2.40 | 2.16 |
| Quick ratio | 0.79 | 1.13 | 0.96 | 1.15 | 1.80 | 1.97 | 1.16 | 1.26 | 1.36 | 1.05 |
| Interest coverage | 3.4 | 2.7 | 2.7 | 5.5 | 5.9 | 6.3 | 5.9 | 7.9 | 11.2 | 8.3 |
| Working capital | $112.9M | $229.1M | $295.7M | $379.8M | $456.0M | $405.3M | $247.7M | $239.4M | $215.3M | $158.3M |
| Invested capital | $1.19B | $1.58B | $2.07B | $2.15B | $1.69B | $1.70B | $1.74B | $1.01B | $643.2M | $592.9M |
| Tangible asset value | −$190.1M | −$303.9M | −$281.4M | −$276.0M | −$105.8M | −$171.3M | −$304.4M | $83.3M | $241.9M | $104.1M |
| Net current asset value | −$1.17B | −$1.33B | −$1.33B | −$1.35B | −$1.07B | −$1.06B | −$1.15B | −$552.9M | −$283.3M | −$403.0M |
| Graham number | — | — | — | $47.40 | $33.40 | $39.12 | $35.10 | $26.68 | $20.90 | $7.72 |
| Graham net-net per share | −$36.79 | −$42.38 | −$43.38 | −$41.77 | −$31.90 | −$29.46 | −$31.71 | −$16.74 | −$9.64 | −$12.41 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | $4.1M | $4.7M | $3.6M | $4.1M | $15.3M | $0 | $448.5M |
| Share buybacks (net) | $56.3M | $3.1M | $92.1M | $145.2M | $109.4M | $88.0M | $6.4M | $47.4M | $6.6M | $300,000 |
| Dividend payout ratio | — | — | — | 1.9% | 4.0% | 2.0% | 2.2% | 9.0% | 0.0% | — |
| Dividends + buybacks / free cash flow | 20.6% | 6.1% | 96.6% | 87.4% | 60.2% | 37.2% | 6.5% | 39.7% | 5.4% | 630.3% |
| Capex / revenue | 4.9% | 5.5% | 6.5% | 8.5% | 7.5% | 8.7% | 8.9% | 8.3% | 5.4% | 6.2% |
| Capex / operating cash flow | 17.4% | 60.3% | 53.5% | 45.5% | 35.4% | 30.1% | 41.6% | 37.3% | 30.2% | 44.3% |
| Capex / depreciation | 0.54 | 0.72 | 0.89 | 1.31 | 0.94 | 1.06 | 1.35 | 1.65 | 1.30 | 1.46 |
| Stock-based compensation / revenue | 1.6% | 0.8% | 0.6% | 1.0% | 0.9% | 0.7% | 1.0% | 1.1% | 1.0% | 0.5% |
| R&D / revenue | 2.4% | 2.0% | 1.9% | 1.8% | 1.9% | 1.9% | 1.5% | 1.9% | 2.0% | 0.8% |
| SG&A / revenue | 14.7% | 11.9% | 10.9% | 11.9% | 12.9% | 12.3% | 12.6% | 11.7% | 10.9% | 12.6% |
| Efficiency | ||||||||||
| Days sales outstanding | 50.1 | 48.5 | 49.6 | 45.0 | 40.6 | 44.7 | 38.0 | 35.2 | 35.6 | 37.2 |
| Days of inventory on hand | 98.7 | 96.8 | 96.3 | 95.8 | 89.3 | 97.6 | 90.9 | 89.5 | 88.3 | 87.0 |
| Days payables outstanding | 48.2 | 48.5 | 49.8 | 50.0 | 47.8 | 49.4 | 43.2 | 44.8 | 46.0 | 41.5 |
| Cash conversion cycle (days) | 100.6 | 96.8 | 96.1 | 90.8 | 82.2 | 92.9 | 85.6 | 79.9 | 77.9 | 82.7 |
| Receivables turnover | 7.29 | 7.53 | 7.35 | 8.12 | 8.99 | 8.16 | 9.62 | 10.36 | 10.25 | 9.82 |
| Payables turnover | 7.57 | 7.53 | 7.32 | 7.31 | 7.64 | 7.38 | 8.45 | 8.15 | 7.93 | 8.80 |
| Inventory turnover | 3.70 | 3.77 | 3.79 | 3.81 | 4.09 | 3.74 | 4.02 | 4.08 | 4.13 | 4.20 |
| Asset turnover | 0.64 | 0.61 | 0.63 | 0.64 | 0.58 | 0.54 | 0.75 | 1.01 | 1.10 | 1.12 |
| Average receivables | $160.2M | $186.8M | $230.2M | $205.5M | $154.8M | $149.0M | $134.4M | $109.5M | $94.9M | $92.5M |
| Average payables | $93.2M | $126.5M | $166.6M | $150.3M | $115.0M | $101.7M | $96.0M | $88.0M | $81.2M | $72.0M |
| Average inventory | $190.9M | $252.3M | $321.9M | $288.1M | $215.1M | $200.8M | $201.9M | $175.7M | $155.6M | $151.1M |
| Intangibles / total assets | 13.3% | 24.7% | 34.8% | 35.6% | 31.6% | 35.1% | 38.9% | 19.5% | 3.8% | 3.7% |
Computed from NGVT's annual financial statements (latest annual report filed February 26, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
NGVT valuation and financial ratios
Based on the latest twelve months, the trailing P/E is 99.7 and the forward P/E is 10.0. Ingevity earned a return on equity of −148.6% and a return on invested capital of 14.9% in fiscal 2025. It ended the year with $1.2 billion of debt and $78.1 million in cash and short-term investments, net debt of $1.2 billion. It returned $56.3 million to shareholders: $0 in dividends and $56.3 million in share buybacks, 21% of free cash flow. The share count fell 14.4% from 42.3M to 36.2M over 9 years.
See the NGVT income statement, the NGVT chart for price history, or the NGVT stock overview for the latest quote and news.
NGVT key metrics FAQ
What is Ingevity's P/E ratio?
Ingevity's trailing P/E ratio is 99.7 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 10.0. At the end of fiscal 2025 it was —, compared with a 10-year median of 21.1.
What is Ingevity's EV/EBITDA?
Ingevity's enterprise value was 88.4 times EBITDA at the end of fiscal 2025 (enterprise value $3.3 billion, EBITDA $37.4 million); the current EV/EBITDA is 17.4.
What is Ingevity's return on equity?
Ingevity's return on equity (ROE) was −148.6% in fiscal 2025: net income of -$167.1 million on average shareholders' equity of $112.5 million.
What is Ingevity's ROIC?
Ingevity's return on invested capital was 14.9% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Ingevity have?
Ingevity had total debt of $1.2 billion at the end of fiscal 2025, a debt-to-equity ratio of 41.84 and $1.2 billion of net debt (31.14 times EBITDA).
Does Ingevity buy back its shares?
Yes. Ingevity spent $56.3 million on net share repurchases in fiscal 2025 Shares outstanding changed −0.3% over the year, to 36.2M..
What is Ingevity's free cash flow yield?
Ingevity generated $273.5 million of free cash flow in fiscal 2025, a free cash flow yield of 12.8% on its market value at year-end ($2.1 billion).
What is Ingevity's current ratio?
Ingevity's current ratio was 1.33 at the end of fiscal 2025: current assets were 1.33 times current liabilities.